Higher expression of CCR6 in lymph node-positive cases compared with N0 and higher expression in high TNM stage cases further suggests that CCR6 is a potential marker in ESCC aggressiveness. The gene discussed is CCR6; the disease is esophageal squamous cell carcinoma.